JPS59204117A - Therapeutic material for external application - Google Patents

Therapeutic material for external application

Info

Publication number
JPS59204117A
JPS59204117A JP58075932A JP7593283A JPS59204117A JP S59204117 A JPS59204117 A JP S59204117A JP 58075932 A JP58075932 A JP 58075932A JP 7593283 A JP7593283 A JP 7593283A JP S59204117 A JPS59204117 A JP S59204117A
Authority
JP
Japan
Prior art keywords
aloe
hydrophilic
water
extract
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58075932A
Other languages
Japanese (ja)
Other versions
JPH0331172B2 (en
Inventor
Tetsuo Horiuchi
堀内 哲夫
Yusuke Ito
祐輔 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Priority to JP58075932A priority Critical patent/JPS59204117A/en
Publication of JPS59204117A publication Critical patent/JPS59204117A/en
Publication of JPH0331172B2 publication Critical patent/JPH0331172B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a therapeutic material for external use, exhibiting strong initial cooling effect without lowering the drug action of aloe, and especially effective as a remedy for scald, by compounding aloe or aloe extract to a hydrophilic hydrous gel substrate, and forming the mixture in the form of a sheet. CONSTITUTION:Aloe or an aloe extract is compounded to a hydrophilic hydrated gel substrate containing 3-30wt% of a hydrophilic polymer and 10-95wt% of water, and the mixture is spread on a carrier and formed in the form of a sheet to obtain the objective material for external use. The hydrophilic polymer is selected from polyacrylic acid, acrylic acid copolymer, maleic anhydride copolymer, water-soluble polyamide, polyvinyl alcohol, etc., and the substrate is preferably incorporated further with a polyhydric alcohol to tackify the substrate and to increase the solubility during the preparation. The amount of aloe added to the material is preferably >=2% as aloe powder of 1-15% as aloe extract.

Description

【発明の詳細な説明】 本発明はシート状外用治療部材に関する。更に詳しくは
、本発明はアロエまたはアロエエキスを含有するシート
状外用治療部材に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a sheet-shaped external treatment member. More specifically, the present invention relates to a sheet-shaped external treatment member containing aloe or aloe extract.

アロエは数f手前から薬草として使用され、明治19年
の日本薬局方にもINtとして記載され、古くから民間
薬として使用されている。
Aloe has been used as a medicinal herb for several centuries, and was listed as INt in the Japanese Pharmacopoeia in 1889, and has been used as a folk medicine since ancient times.

アロエの効能は下記のようなものである二内用としては
、胃腸病に対する健冑作用、冑カイヨウ、十二指腸カイ
ヨウに対する従カイヨウ剤、便秘に対する下剤、高血圧
に対する合併症の防止、低血圧に対する血液の循環向上
、かゼに対するウィルスの不活化、ゼンソクに対する体
質改善、糖尿病に対する新陳代謝の活性化、肝蔵病に対
する解毒作用、乗p物酔いに対する鎮経作用、二日酔い
に対する解挿作用、など外用としては、やけど、すり傷
、切り傷に対する殺菌作用と組織回復作用、虫さされて
対する収態作用と毒素中和作用、水虫に対する殺菌作用
、うおのめに対する角質軟化作用、虫歯;歯槽膿漏に対
する消炎作用口内炎に対する殺菌作用、打ち身・肩こり
に対する消炎作用、痔に対する消炎鎮痛止血作用などが
ある。
The effects of aloe are as follows.For internal use, it has a laxative effect on gastrointestinal diseases, a laxative for gastrointestinal disorders, a laxative for constipation, prevention of complications for high blood pressure, and a blood thinner for low blood pressure. External use includes improving circulation, inactivating viruses for colds, improving constitution for colds, activating metabolism for diabetes, detoxifying effects for liver disease, calming effects for motion sickness, and soothing effects for hangovers. Sterilizing effect and tissue recovery effect on burns, abrasions, and cuts, astringent effect and toxin neutralizing effect on insect bites, bactericidal effect on athlete's foot, keratin softening effect on corns, anti-inflammatory effect on cavities and alveolar pyorrhea, and sterilization effect on stomatitis. It has an anti-inflammatory effect on bruises and stiff shoulders, and an anti-inflammatory analgesic and hemostatic effect on hemorrhoids.

以上のよってアロエは種々の薬効を有し、使用に際して
は、目的に応して、生のアロエ、ジュース、液汁、軟膏
、錠剤等を服用又は塗布して使用する。
As described above, aloe has various medicinal effects, and depending on the purpose, raw aloe, juice, liquid, ointment, tablet, etc. are taken or applied.

ところで、アロエの外用用途で最も効果が期待され、ま
た効果の大きいやけど、切り傷、すり傷の沼療用として
1史用する場合、初期治療は早ければ早い方がよい。特
にやけど証対する治療の場合は緊急を用する、したかつ
て市販の軟膏剤を常備し1更用することは好ましい。
By the way, if aloe vera is to be used externally as the most effective and highly effective treatment for burns, cuts, and abrasions, the earlier the initial treatment, the better. Particularly in the case of treatment for burns, it is preferable to keep a commercially available ointment on hand and use it once in an emergency.

また、やけど治療において重要なことは、できるだけ速
やかに治療することはもちろんであるが、患部の冷却か
必要であり、この初期冷却の度合によって回復の速さか
決定する。その照尺おいて軟骨剤は初1t/l冷却作用
が得られない欠Qかある。また、家庭で栽培しているア
ロエを熱湯にくぐらせ殺菌した代に外皮を収り除いて葉
の中のゼリー状の部分を患部を広く並べて貼り付ける治
療はアロエ中に含まれている多量の水分量よる冷却効果
が期待できると同時にアロエの薬効成分を直接患部に作
用さぜりるという利点があり、よく知られた使用方法で
は有るが、操作がめんどうなために時開がかかる欠点が
有った。
In addition to treating burns as quickly as possible, it is important to cool the affected area, and the degree of initial cooling determines the speed of recovery. In that light, the cartilage agent is lacking in its ability to provide a cooling effect of 1 t/l. In addition, a treatment in which aloe grown at home is sterilized by soaking it in boiling water, removing the outer skin, and applying the jelly-like part of the leaf to the affected area in a wide array is a treatment that removes the large amount of aloe contained in aloe. It has the advantage of having a cooling effect due to the amount of water, and at the same time applying the medicinal ingredients of aloe directly to the affected area.Although it is a well-known method of use, it has the disadvantage that it is cumbersome to operate and takes time to open. There was.

本発明の目的は、アロエの薬効を損なわず初期冷却効果
の大きいアロエ製剤を得ることにあり、その要旨は親水
性含水ケル基剤にアロエまたはアロエエキスを配合し、
シート状に成形してなる外用治療部材である。
The purpose of the present invention is to obtain an aloe preparation with a large initial cooling effect without impairing the medicinal efficacy of aloe, and its gist is to blend aloe or aloe extract into a hydrophilic hydrous gel base,
This is an external treatment member formed into a sheet shape.

本発明に関して、親水性含水ゲル基剤としては。Regarding the present invention, as a hydrophilic hydrogel base.

通常、従来から一般的に使用されているものか用いられ
る。それは合成、天然のいずれでもよく、従来から親水
性ゲル基剤用として用いられているものはいずれも使用
用船である。その代表例としては、たとえばアルギン酸
ナトリウム、アラヒアゴム、デキストリン、プルラン ラチン、カードライン、メチルセルロースルセルロース
、ヒドロキシエチルセルロース、ヒドロキシプロピルセ
ルロース、カルボキシメチルセルロースなどの糖類およ
びその訪専俸、ポリアクリル酸およびその塩(たとえば
、ナトリウム塩、アンモニウム塩、アルカノールアミ/
塩など)、アクリル酸共重合体およびその塩(たとえば
、アクリル酸・アクリル酸エチル共重合体、アクリル酸
・アクリル酸エチル共重合体のカリウム塩など)、アク
リル酸アルキルエステル重合体(たとえば、ポリアクリ
ル酸エチル、ポリアクリル酸ヒドロキシエチル、ポリア
クリル酸エトキシエチル)、無水マレイン酸共重合体(
たとえば、メチルビニルエーテル・無水マレイン酸共重
合体、インブチレン・無水マレイン酸共重合体など)お
よびその塩(たとえは、ナトリウム塩、アンモニウム塩
など)、ポリビニルアルコールおよびそのMe体(たと
えば、部分グン化ボリヒニルアルコール、カルホキモル
化ボリヒニルアルコールなと)、アクリルアミド1合体
およびその共重合体(たとえば、アクリルアミド・アク
リル酸共重合体、アクリルアミド・アクリルニトリル・
アクリル酸共重合体、アクリルアミド・アクリルニトリ
ル・アクリル酸エステル共重合体など)、ポリビニルピ
ロリトノなどがあけられる。かかる高分子物質は架橋剤
(たとえば、ポリイソシアネート、ポリエポキシド、過
酸化ベンゾイルなど)を用いて架橋されたものであって
もよい。
Usually, one that has been commonly used in the past is used. It may be either synthetic or natural, and any of those conventionally used for hydrophilic gel bases can be used. Representative examples include saccharides and their compounds, such as sodium alginate, gum arahya, dextrin, pullulanlatin, curdline, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and carboxymethylcellulose, polyacrylic acid and its salts (for example, Sodium salt, ammonium salt, alkanolamide/
salts, etc.), acrylic acid copolymers and their salts (e.g., acrylic acid/ethyl acrylate copolymers, potassium salts of acrylic acid/ethyl acrylate copolymers, etc.), acrylic acid alkyl ester polymers (e.g., ethyl acrylate, hydroxyethyl polyacrylate, ethoxyethyl polyacrylate), maleic anhydride copolymer (
For example, methyl vinyl ether/maleic anhydride copolymer, imbutylene/maleic anhydride copolymer, etc.) and their salts (e.g., sodium salt, ammonium salt, etc.), polyvinyl alcohol and its Me form (e.g., partially gunned (such as borihinyl alcohol, carphokimolated borihinyl alcohol), acrylamide monomers and their copolymers (e.g., acrylamide/acrylic acid copolymer, acrylamide/acrylonitrile,
Acrylic acid copolymers, acrylamide/acrylonitrile/acrylic acid ester copolymers, etc.), polyvinylpyrrolitonos, etc. Such polymeric substances may be crosslinked using a crosslinking agent (eg, polyisocyanate, polyepoxide, benzoyl peroxide, etc.).

親、水性含水ゲル基剤における当該高分子物質の配合量
は、当該基剤の強度および冷却能の設定によって異なる
が、通常3〜30重餉千程度である。
The blending amount of the polymeric substance in the parent aqueous hydrogel base varies depending on the strength of the base and the setting of the cooling capacity, but is usually about 3 to 30%.

8重量多以下では、たとえ架橋体の状態で用いても含水
ゲル強度が不十分であす、3071′!量チ以上では製
造時の粘度が高すぎて作業性が悪く、高分子物質の溶解
性の点から配合用能な水分量が少なくなり冷却能が悪く
なる傾向がある。
If the weight is less than 8%, the hydrogel strength will be insufficient even if it is used in a crosslinked state, 3071'! If the amount exceeds 1, the viscosity during production is too high, resulting in poor workability, and the amount of water that can be blended decreases in view of the solubility of the polymeric substance, which tends to result in poor cooling performance.

また、基剤中には粘着付与や製造時の溶解性を高める目
的でエチレングリコール、ジエチレ/グリコール、ポリ
エチレングリコール、フロピレン′グリコール、ボリフ
゛ロビレングリコール、グリセリンなどの多価アルコー
ルを併用することが好ましく、その使用量は、通常5〜
80重量%である。
In addition, it is preferable to use a polyhydric alcohol such as ethylene glycol, diethyl glycol, polyethylene glycol, fluoropylene glycol, polypropylene glycol, or glycerin in the base material for the purpose of tackification and improving solubility during manufacturing. , the amount used is usually 5~
It is 80% by weight.

5重量%以下では添加したことによる顕著な効果が得ら
れず、80重量%以上では、含水ゲル強度と冷却能が劣
る。
If it is less than 5% by weight, no significant effect can be obtained by adding it, and if it is more than 80% by weight, the strength of the hydrogel and the cooling ability will be poor.

親水性含水ゲル基剤中の水分量は104道斧以上であれ
ば冷却効果は期待できるが、20重量%以下では冷却効
果の消失が速く、95Mkk’l1以上では、含水ケル
強度が不十分なために、形状や大きさによっては使いす
らい。したがって、好ましい含水量は、使用される高分
子物質によっても若干異なるが、25〜70M量襲、さ
らに好ましくは30〜60重量%である。
If the water content in the hydrophilic hydrogel base is 104% by weight or more, a cooling effect can be expected, but if it is less than 20% by weight, the cooling effect disappears quickly, and if it is more than 95Mkk'l1, the hydrogel strength is insufficient. Therefore, it can be used depending on its shape and size. Therefore, the preferred water content is 25 to 70 M, more preferably 30 to 60% by weight, although it varies slightly depending on the polymer material used.

薬効成分としてはアロエまたはアロエエキスが配合され
るが、目的に応じて、既知の殺菌剤、抗炎症剤、防騙M
IJ、充填剤、第1級アルコール等全添加してもよい。
Aloe or aloe extract is blended as a medicinal ingredient, but depending on the purpose, known bactericides, anti-inflammatory agents, anti-deception M
IJ, filler, primary alcohol, etc. may all be added.

アロエとしては、局方記載のもの(クーゾアロエ、ソコ
トラ・アロエ、キュラソウ・アロエ)を用いることが好
−ましいが、もちろん池のアロエ属、たとえばナタルア
ロエ、デンバーアロエ、シャツアラパッドアロエなどを
用いてもよい。アロエは、その粉末、アロエ液汁、アロ
エエキスで添加してもよい。アロエエキスとしては、た
とえば水、エタノール等のアルコール、水−アルコーl
vmAK媒などによって抽出して装したものか1史用さ
れる。
As aloe, it is preferable to use those listed in the pharmacopeia (Cuzo aloe, Socotra aloe, Curacao aloe), but of course, it is also possible to use pond aloe such as Natal aloe, Denver aloe, Shirtarapad aloe, etc. Good too. Aloe may be added in the form of its powder, aloe juice, or aloe extract. Examples of aloe extracts include water, alcohol such as ethanol, and water-alcohol.
It has been used for some time since it was extracted and mounted using a vmAK medium or the like.

アロエマタハアロエエキスの配合md、70工またはア
ロエ木として2%以上、上記のエキスとして0.84以
上であれは効果!′iルJ侍できるか、エキス含酸とし
て1〜15%が好適である。
If the blend md of Aloe Mataha aloe extract is 2% or more as 70g or aloe wood, and 0.84 or more as the above extract, it will be effective! The acid content of the extract is preferably 1 to 15%.

木兄りJの治療部材は親水性古木ケル基剤中にアロエ類
を均一に分散又は溶P#さぞ、こh全担持体主尺延展す
ることによって製造される。
Kineri J's therapeutic components are manufactured by uniformly dispersing or dissolving aloe in a hydrophilic Koki base and spreading the whole carrier over the entire length.

担持体としては布、プラスチック等従来既知のものを用
いればよい。
As the carrier, conventionally known carriers such as cloth and plastic may be used.

以”Fに実施例及び医検測を示して不発1313をより
具体的に説明するが、木兄りjはこれらf眠γされるも
のではない。
Hereinafter, the misfire 1313 will be explained in more detail by showing an example and a medical inspection, but this is not something that can be ignored.

なお、以下の記載において「都」とあるは[]j鼠61
月を鮭味する。
In addition, in the following description, "Miyako" refers to [ ]j 61
The moon tastes like salmon.

実施例1 平均重合度20000のポリアクリル畝ソーダ6部及び
グリセリン15部を水80部に溶解する。
Example 1 Polyacrylic ridge having an average degree of polymerization of 20,000 6 parts of soda and 15 parts of glycerin are dissolved in 80 parts of water.

−力トリグリシジルイソシアヌレ−)0.3都を水lO
都て溶解する。次にポリアクリル酸ソーダとグリセリン
の水giを攪拌しながらトリグリシジルイソシアスレー
ト水泌液を添加し、約70°Cで1時間加温後冷却し、
アロエの生葉をしばった液7十50部全添加混合する。
- triglycidyl isocyanurate -) 0.3 liters of water
It dissolves completely. Next, while stirring the sodium polyacrylate and glycerin water gi, triglycidyl isocyanate water was added, heated at about 70°C for 1 hour, and then cooled.
Add all 750 parts of liquid made from fresh aloe leaves and mix.

この混合物をレーヨン不織布に厚みが1.0間となるよ
うに塗布し、木兄りJのPi療部材を得る。
This mixture is applied to a rayon nonwoven fabric to a thickness of 1.0 mm to obtain a Pi medical member.

実施例2 アクリル酸90都、アクリル酸ブチル10部、ポリオキ
シプロピル化ソルヒトール50部、過硫酸アンモニウム
2都を水350都に溶解し、不活性ガス気ぴL中で60
°Cで8時間重合した。得られた粘稠液100部にポリ
オキシプロピル化ソルヒトール60都、20%水酸化カ
リウム水〆gB。
Example 2 90 parts of acrylic acid, 10 parts of butyl acrylate, 50 parts of polyoxypropylated sorbitol, and 2 parts of ammonium persulfate were dissolved in 350 parts of water, and 60 parts of the solution was dissolved in an inert gas atmosphere.
Polymerization was carried out at °C for 8 hours. To 100 parts of the obtained viscous liquid, add 60 g of polyoxypropylated sorbitol and 20 g of 20% potassium hydroxide water.

都、10%トリグリシジルイソシアヌレート水溶故10
都を加え均一に混合した後、局方アロエの水性エキス4
0部した液を添加混合し、厚さ100μのレーヨン不織
布に厚さ約1mとなるように展延しシート状治療部材を
得る。
Miyako, 10% triglycidyl isocyanurate water soluble 10
Add the water and mix evenly, then add the water-based extract of aloe
The 0 part solution was added and mixed, and spread on a rayon nonwoven fabric with a thickness of 100 μm to a thickness of about 1 m to obtain a sheet-like treatment member.

実施例8 無水マレイノ酸・メチルビニルエーテル共重合体(無水
マレイン酸含有量50重重%)20条水溶液10081
SK、ジエチレングリコール15 ffl東トリエクノ
ー)Vアミン1都を加えて混合し、均一に混合された後
に10%グリセリンシグリシシルエーテル水に;’le
i 20部と局方アロエ末50都を添加しレーヨン不織
布に厚みが1.Onとなるように塗布し、′縫温で架′
橋して本発明の治療部材を得る。
Example 8 Maleinoic anhydride/methyl vinyl ether copolymer (maleic anhydride content 50% by weight) 20 strips aqueous solution 10081
SK, diethylene glycol 15 ffl East Triechnol) Add V amine 1 and mix, and after uniformly mixing, add 10% glycerin siglycyl ether in water;'le
20 parts of I and 50 parts of pharmacopoeial aloe powder were added to the rayon nonwoven fabric to a thickness of 1. Apply it so that it turns on, and then heat it up at the sewing temperature.
The treatment member of the present invention is obtained by bridging.

実施例 実施例1〜3で得た製剤を第1表に示す火傷に適用し、
その効果の判定を行い、その結果を第1汲例示した。
Examples The preparations obtained in Examples 1 to 3 were applied to the burns shown in Table 1,
The effectiveness was evaluated and the results were presented as a first example.

以上の結果から明らかなように、不発町治療部@は中敷
のアロエ軟責に比し良好な治療効果を得た。
As is clear from the above results, Fukacho Treatment Department @ had a better therapeutic effect than the aloe insole.

払下余色leftover color

Claims (4)

【特許請求の範囲】[Claims] (1)親水性含水ケル基剤にアロエまたはアロエエキス
を配合し、シート状に成梨してなる外用治療部材。
(1) An external treatment material prepared by blending aloe or aloe extract with a hydrophilic hydrogel base and forming it into a sheet.
(2)親水性含水ゲル基剤中の水含量が10〜95重量
係である特許請求の範囲第(0項記載の外用治療部材。
(2) The external treatment member according to claim 0, wherein the water content in the hydrophilic hydrogel base is 10 to 95% by weight.
(3)親水性含水ゲル基剤がポリアクリル酸およびその
塩、アクリル酸共重合体およびその塩、無水マレイノ酸
共重合体およびその塩、水溶性ポリアミド、ボリヒニル
アルコールおよびその誘等体ならびに糖類およびその誘
導体から選ばれる少なくとも一種の親水性高分子物質よ
りなるものである特gf請氷の範囲第(1)項記載の外
用治療部材。
(3) The hydrophilic hydrogel base is polyacrylic acid and its salts, acrylic acid copolymers and their salts, maleic anhydride copolymers and their salts, water-soluble polyamides, borihinyl alcohol and its derivatives, and The external therapeutic device according to item (1), which is made of at least one hydrophilic polymeric substance selected from saccharides and derivatives thereof.
(4)親水性含水ゲル基剤が8〜30重箪チの親水性高
分子物質を含有するものである特許請求の範囲第(1)
又は(2)項記載の外用治療部材。
(4) Claim No. 1, wherein the hydrophilic hydrogel base contains 8 to 30 layers of hydrophilic polymeric material.
Or the external treatment member described in (2).
JP58075932A 1983-04-28 1983-04-28 Therapeutic material for external application Granted JPS59204117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58075932A JPS59204117A (en) 1983-04-28 1983-04-28 Therapeutic material for external application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58075932A JPS59204117A (en) 1983-04-28 1983-04-28 Therapeutic material for external application

Publications (2)

Publication Number Publication Date
JPS59204117A true JPS59204117A (en) 1984-11-19
JPH0331172B2 JPH0331172B2 (en) 1991-05-02

Family

ID=13590525

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58075932A Granted JPS59204117A (en) 1983-04-28 1983-04-28 Therapeutic material for external application

Country Status (1)

Country Link
JP (1) JPS59204117A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63310818A (en) * 1987-06-12 1988-12-19 Sato Seiyaku Kk Sheet preparation to be applied to oral mucosa
JPH08291057A (en) * 1995-02-22 1996-11-05 Yuutoku Yakuhin Kogyo Kk Cataplasm
KR20020008886A (en) * 2000-07-20 2002-02-01 이상영 Burn dermatitis from natural materials and preparation method thereof
JP2007320886A (en) * 2006-05-31 2007-12-13 Isp Japan Kk Hydrogel-like sheet agent and its production method

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63310818A (en) * 1987-06-12 1988-12-19 Sato Seiyaku Kk Sheet preparation to be applied to oral mucosa
JPH044296B2 (en) * 1987-06-12 1992-01-27
JPH08291057A (en) * 1995-02-22 1996-11-05 Yuutoku Yakuhin Kogyo Kk Cataplasm
KR20020008886A (en) * 2000-07-20 2002-02-01 이상영 Burn dermatitis from natural materials and preparation method thereof
JP2007320886A (en) * 2006-05-31 2007-12-13 Isp Japan Kk Hydrogel-like sheet agent and its production method
WO2007142280A1 (en) * 2006-05-31 2007-12-13 Shin-Etsu Chemical Co., Ltd. Hydrogel sheet and production method thereof

Also Published As

Publication number Publication date
JPH0331172B2 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
JP2007512410A (en) Skin adhesive hydrogel
JPH0791397B2 (en) Flexible hydrophilic gel film, and method of making and using the same
CN103491778B (en) The dennophannaceutical compositions and its application method of 1 methyl N (2,6 xylyl) 2 piperidine formamides
TW201313208A (en) Topical patch cooling preparation and methods for using the same
EP1490038B1 (en) Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
GB2362825A (en) External patch for a nonsteroidal antiinflammatory drug
JP4596751B2 (en) Anti-inflammatory analgesic patch
JP2002020274A (en) Non-steroidal anti-inflammatory analgesic transdermal patch agent for outer application and transdermal patch for outer application
US20060079640A1 (en) Adhesive composition for dermal patch and production process thereof
WO2002098464A3 (en) Liquid polymer composition for prevention and treatment of the oral cavity diseases
JP3908275B2 (en) Cold seat
JPH05502894A (en) Controlled release formulations and methods
JP2003070898A (en) Plaster and production method thereof
RU2249467C2 (en) Medicinal material and products based upon this material
JP4575632B2 (en) Drugs for migraine relief
JPS59204117A (en) Therapeutic material for external application
JP6495572B2 (en) Homeopathic therapeutic methods and compositions
JPH08243377A (en) Alcohol-containing gel body
JP5175041B2 (en) Hydrophilic adhesive, hydrophilic external skin adhesive composition and hydrophilic patch using the same
JP2001302501A (en) Percutaneous patch material for treating shoulder shiffness, knee joint pain, frozen shoulder and the like
JPS6034923B2 (en) Sponge-like medical band
JP3145857B2 (en) Aqueous warming patch
JP2001151973A (en) Alkaline hydrous gel
CN107595819B (en) A kind of Nano diamond modified liquid adhesive bandage and preparation method thereof
JP3157082B2 (en) Base for medical pack-type preparation and pack-type preparation for medical use